liposomal glutathione lymphatic absorption Hybrid Lymphatic Drug Delivery Vehicles
Description
Abstract The development of new drugs is a lengthy and complex process regarding its conception and ideation, passing through in silico studies, synthesis, in vivo studies, clinical trials, approval, and commercialization, with an exceptionally low success rate
They belong to the same class of drugs, have similar mechanisms of action, and are self-administered as subcutaneous injections
Reducing LGG or butyrate diminished Treg counts and eliminated the pro-osteogenic effects
doi: 10.3389/fimmu.2021.790803
